U.S. Markets closed

Shares of cancer-therapy companies skyrocket after Pfizer acquisition news

Sarah Toy
Shares of cancer-therapy companies skyrocket after Pfizer acquisition news

Shares of gene-therapy companies shot up on Monday after Pfizer Inc. announced it would acquire cancer drug maker Array BioPharma Inc. in a deal worth up to $11.4 billion.